Latest Commercial Operations News

Critica Limited has produced its first commercial-quality Mixed Rare Earth Carbonate from the Jupiter Rare Earth Project, marking a key milestone in advancing its development and processing pathway. The high-grade product validates scalable hydrometallurgical processing and supports the upcoming Scoping Study.

Prairie Lithium has begun installing foundation piles and grade beams at its flagship Pad #1 site, marking a significant step towards commercial lithium production. Concurrent construction of prefabricated panels aims to accelerate the project timeline.

Ionic Rare Earths is advancing its rare earth magnet recycling ambitions with strategic leadership relocation, government recognition, and new funding discussions. The company’s Belfast facility gains global significance as it targets key international markets.

International Graphite Limited has secured key approvals and funding to progress its Collie Micronising Facility and European Expandable Graphite Project, positioning itself as a major supplier outside China.

4DMedical has rapidly commercialised its CT – VQ™ lung imaging technology following FDA clearance, securing major partnerships and regulatory approvals that position it for significant growth in North America.

Artrya Limited has converted three US foundation partners into commercial customers, generating its first fee-per-scan revenues, while progressing FDA clearance for its Salix Coronary Flow module and expanding its clinical study network.

First Graphene Limited has reported a landmark quarter with a 156% surge in customer cash receipts and a major industrial-scale production of graphene-enhanced cement, signalling a pivotal step in commercialising graphene across multiple sectors.

InteliCare Holdings has advanced its aged care technology deployments and is close to appointing a new CEO, signalling a pivotal growth phase. The company also reported progress in commercial talks and product enhancements.

Mesoblast Limited reported a 60% jump in Ryoncil sales to US$35 million for the December quarter, alongside securing a US$125 million credit facility that enhances its financial flexibility and supports ongoing clinical development.

Alpha HPA Limited has raised A$225 million in a fully underwritten placement to fund the commercialisation of Stage 2 of its High Purity Alumina project, with strong backing from the National Reconstruction Fund Corporation. This capital injection positions the company to become the world’s largest single-site HPA manufacturer, supporting critical semiconductor supply chains.

dorsaVi reports strong US commercial growth with over 100 new physical therapy sites and a 50% rise in cash receipts, alongside a strategic leadership change and breakthrough neuromorphic technology acquisition.

Sea Forest Limited has exceeded its breakeven target for its methane-reducing feed additive SeaFeed™, securing commitments for over 118,000 cattle and expanding commercial trials with major industry partners.